Stago introduces a new flow analysis service: MyOptiLab
The new MyOptiLab workflow analysis service is part of a broader strategy aimed at working more closely with laboratories. It is an elaborate process designed to optimise organisational excellence.
Read more
World Health Day 2021. Health for all!
7 April is World Health Day. As the pandemic lingers on, health issues as well as health-related local, national and international governance issues have never been more at the forefront of public attention and concerns.
Read more
COVID-19 infection and thrombotic disorders
Since December 2019, a new type of pneumonia defined as coronavirus disease 2019 (COVID-19) is spreading worldwide and affecting an increasing number of people every day. Main symptoms are fever and cough, and most of patients recover spontaneously.
Read more
Health Economics Outcomes evaluation of Stago D-dimer
Improved patient outcomes and experience, shorter length of stay and cost effectiveness drive the recognition of value in today’s rapidly-evolving and competitive healthcare environment.
Read more
FDA grants de novo for the HemoSonics’ Quantra System
March 13, 2019 : Stago is proud to announce that HemoSonics, a Stago Group company, has been granted de novo marketing authorization by the FDA for its revolutionary diagnostic device Quantra Hemostasis Analyzer platform, and its initial QPlus cartridge. The system is now commercially available in the USA.
Read more